Carnick & Kubik’s Novo Nordisk NVO Stock Holding History

Carnick & Kubik’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.52M	Buy	55,988 +920	+2%	+$24.6K	0.45%	37
2015 Q4	$1.6M	Buy	55,068 +2,878	+6%	+$79.7K	1.03%	24
2015 Q3	$1.42M	Buy	52,190 +7,110	+16%	+$201K	0.99%	21
2015 Q2	$1.23M	Sell	45,080 -20	-0%	-$562	1.01%	28
2015 Q1	$1.2M	Buy	45,100 +2,320	+5%	+$53.4K	1%	30
2014 Q4	$905K	Buy	42,780 +30	+0.1%	+$670	0.77%	43
2014 Q3	$1.02M	Buy	42,750 +340	+0.8%	+$7.82K	0.94%	29
2014 Q2	$979K	Hold	42,410	–	–	0.98%	34
2014 Q1	$968K	Sell	42,410 -163,140	-79%	-$3.48M	0.92%	33
2013 Q4	$3.8M	Buy	+205,550	New	+$3.58M	3.44%	5

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Carnick & Kubik's NVO Position: Q1 2016 in Review

Carnick & Kubik increased its Novo Nordisk (NVO) stake by 1.7% in Q1 2016, buying an estimated $24.6K and bringing the position to 55,988 shares worth $1.52M. The position accounts for 0.45% of the portfolio, ranked #37.

Carnick & Kubik first reported a position in NVO in Q4 2013 and has held it in 10 quarters since. The position peaked at $3.8M in Q4 2013. 535 funds tracked by Wall St. Rank hold NVO as of Q1 2016.

Carnick & Kubik held 55,988 shares of Novo Nordisk worth $1.52M as of Q1 2016.
Carnick & Kubik bought 920 Novo Nordisk shares in Q1 2016, an estimated $24.6K.
Novo Nordisk made up 0.45% of Carnick & Kubik's portfolio in Q1 2016, its #37 holding.
Carnick & Kubik first reported a position in Novo Nordisk in Q4 2013 and has held it in 10 quarters since.
Carnick & Kubik's Novo Nordisk position peaked at $3.8M in Q4 2013.
535 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.